Form 4: RxSight Executive Eric Weinberg Granted Stock Options

Eric Weinberg, Co-President and Chief Commercial Officer of RxSight, Inc., was granted stock options to purchase 50,000 shares of common stock on August 7, 2024.

Summary

• Eric Weinberg, an officer at RxSight, Inc., received stock options for 50,000 shares.
• The options were granted on August 7, 2024, with an exercise price of $46.24 per share.
• The options vest monthly over a four-year period, starting from August 7, 2024, contingent upon continued service.
• A Power of Attorney was executed on June 13, 2024, granting certain individuals the authority to act on behalf of Eric Weinberg in matters related to securities filings.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed neutrally to positively as it aligns management interests with shareholders.

Positives

• The granting of stock options aligns the executive's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the stock options.

Industry Context

Stock option grants are a common practice in the industry to incentivize and retain key executives.

Stakeholder Impact

• The stock option grant could potentially increase shareholder value if the executive's performance drives company growth.
• The grant incentivizes the executive, potentially benefiting employees through improved company performance.

Key Dates